PAVmed Inc.
PAVM· Nasdaq
Released Mar 13, 2023, after the close
10-K filed Mar 14, 2023, 73 days after period end · 0001493152-23-007481
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | $112.00K | — | — | — |
| Net Income | -$20.46M | -$17.22M | -$8.74M |
PAVmed Inc. · CIK 1624326 · Engraved from SEC EDGAR
| -$6.24M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.